28.69  -1.33 (-4.43%)		04-19 16:00
Open: 29.98 High: 30.055 Volume: 551,203		Pre. Close: 30.02 Low: 28.09 Market Cap: 708(M)

Short term
Mid term
Targets	6-month :	61.12	1-year :	80.42
Resists	First :	52.33	Second :	68.86
Pivot price	31
Supports	First :	25.6	Second :	21.29
MAs	MA(5) :	29.88	MA(20) :	38.41
	MA(100) :	58	MA(250) :	50.66
MACD	MACD :	-8.2	Signal :	-8.3
%K %D	K(14,3) :	18.6	D(3) :	14.4
RSI	RSI(14): 22.8
52-week	High :	77.59	Low :	25.6

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ IRON ] has closed above bottom band by 6.7%. Bollinger Bands are 64% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	30.11 - 30.28	30.28 - 30.47
Low:	27.63 - 27.81	27.81 - 28.01
Close:	28.34 - 28.66	28.66 - 29.01

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Fri, 19 Apr 2024
Disc Medicine (NASDAQ:IRON) Shares Down 4.1% - MarketBeat

Mon, 15 Apr 2024
Insider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells 2,560 Shares of Stock - MarketBeat

Mon, 15 Apr 2024
Disc Medicine, Inc. (NASDAQ:IRON) Sees Large Growth in Short Interest - MarketBeat

Thu, 04 Apr 2024
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More - Markets Insider

Tue, 02 Apr 2024
Disc Medicine (IRON) Down on Mixed Results From AURORA Study - Yahoo Finance

Mon, 01 Apr 2024
Attention Disc Medicine, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	25 (M)
Shares Float	14 (M)
Held by Insiders	13.3 (%)
Held by Institutions	84.9 (%)
Shares Short	1,860 (K)
Shares Short P.Month	1,190 (K)

EPS	-3.43
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	14.17
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-20.1 %
Return on Equity (ttm)	-29.3 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-3.69
Qtrly Earnings Growth	0 %
Operating Cash Flow	-73 (M)
Levered Free Cash Flow	-54 (M)

PE Ratio	-8.39
PEG Ratio	0
Price to Book value	2.02
Price to Sales	0
Price to Cash Flow	-9.64

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.